Status:
COMPLETED
Pulmonary Surfactant(PS) Therapy at High Altitude Area
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Collaborating Sponsors:
the first people hospital of Tibet autonomous region
the second people hospital of Lasa
Conditions:
NRDS
Surfactant
Eligibility:
All Genders
1-12 years
Brief Summary
The traditional concept believes that the etiology of neonatal respiratory distress syndrome (RDS) is immature development of lung,especially the surfactant synthesis system,and RDS is still one of th...
Detailed Description
in order to explore feasibility and efficacy for PS treatment of newborn RDS in high-altitude area ,and its efficacy at different altitudes, the investigators conduct a multi-center retrospective stud...
Eligibility Criteria
Inclusion
- diagnosed with respiratory distress syndrome(RDS)
Exclusion
- major congenital abnormalities
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03440333
Start Date
January 1 2015
End Date
December 31 2017
Last Update
February 27 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.